Liver transplantation in Australia and New Zealand.

about

Addiction medicine ethics: relapse, no lapse and the struggle to treat addicts like everyone else.

P2860

Q48217669-7CF2B680-7CB5-49D1-8798-E8DF839DECEF

P2860

Liver transplantation in Australia and New Zealand.

Item

http://www.wikidata.org/entity/Q39877508

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Liver transplantation in Australia and New Zealand.

@en

Liver transplantation in Australia and New Zealand.

@nl

type

Item

label

Liver transplantation in Australia and New Zealand.

@en

Liver transplantation in Australia and New Zealand.

@nl

prefLabel

Liver transplantation in Australia and New Zealand.

@en

Liver transplantation in Australia and New Zealand.

@nl

P1476

Liver transplantation in Australia and New Zealand.

@en

P2093

Stephen R Munn

http://www.w3.org/2001/XMLSchema#string

P2860

A model to predict survival in patients with end-stage liver disease

Early indicators of prognosis in fulminant hepatic failure

Poorer survival in patients whose explanted hepatocellular carcinoma (HCC) exceeds Milan or UCSF Criteria. An analysis of liver transplantation in HCC in Australia and New Zealand

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.

Liver transplantation outcomes for Australian Aboriginal and Torres Strait Islanders.

Additive impact of pre-liver transplant metabolic factors on survival post-liver transplant.

Liver transplantation for HCV-associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution.

Nature and outcomes of the increased incidence of colorectal malignancy after liver transplantation in Australasia.

Minimal but significant improvement in survival for non-hepatitis C-related adult liver transplant patients beyond the one-year posttransplant mark.

Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates.

P304

830-838

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/LT.24446

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Geoffrey W McCaughan

P577

2016-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27028552

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation

Australia

New Zealand

Liver transplantation in Australia and New Zealand.

about

P2860

P2860

Liver transplantation in Australia and New Zealand.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921